TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function

DOI: 10.1080/2162402X.2016.1230578

Keywords: Immunotherapy, MDSC, myeloid-derived suppressor cells, R848, TLR7

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text